Gold Nanoparticles in Cancer Therapy: Efficacy, Biodistribution, and Toxicity

Current Pharmaceutical Design
Jun ZhaoMarites P Melancon

Abstract

Gold-based nanoparticles are utilized for cancer therapeutics as a system for drug delivery, or as a mediator for thermal therapy, whether ablation or hyperthermia. This review discusses how the design of the physicochemical properties of the different types of gold-based nanoparticles affects their treatment efficacy. The basic principles and mechanism at which it mediates heating and delivers drugs efficiently in vivo is also summarized. We will also review the in vivo preclinical data on the biodistribution, intratumoral distribution, cell internalization, and its associated toxicity. Lastly, an updated list of the clinical trials based on nanoparticles and future perspectives are provided.

Citations

Sep 2, 2016·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Rachael MooneyJacob M Berlin
Oct 4, 2016·Bioconjugate Chemistry·Nan-Sheng LiJoseph A Piccirilli
May 17, 2018·Medicinal Research Reviews·Florence MasseElodie Boisselier
Jun 26, 2018·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·L LarueC Frochot
Sep 13, 2018·Journal of Drug Targeting·Fabiana de Sousa CunhaAnderson Nogueira Mendes
Mar 18, 2020·Critical Reviews in Food Science and Nutrition·Mahboobeh ZareSeid Mahdi Jafari
Jun 7, 2020·Nanomaterials·Laura JuhászCsaba Cserháti
Jul 1, 2017·Biomedical Optics Express·Vesna CuplovSébastien Jan
Jun 6, 2018·Annual Review of Biomedical Engineering·John C Bischof, Kenneth R Diller
Apr 3, 2020·Electromagnetic Biology and Medicine·Sundeep Singh, Roderick Melnik
Aug 24, 2021·Environmental Science and Pollution Research International·Meenu SinghSuresh Vir Singh Rana

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
O S NielsenJ Overgaard
Current Topics in Medicinal Chemistry
A B SalunkheS H Pawar
© 2021 Meta ULC. All rights reserved